EDIT Linda Burkly sells $13K worth of shares
Aug 05, 2025, 4:36 AM
0.00%
What does EDIT do
Editas Medicine, headquartered in Cambridge, Massachusetts, specializes in genome editing technology and developed a proprietary CRISPR-based platform for transformative genomic medicines. Its lead program, reni-cel, aims to treat sickle cell disease and beta thalassemia.
Linda Burkly sold 5,121 shares of EDIT on 31 July at $2.49 per share, worth a total of $13K. They now own 64,398 EDIT shares, or a 7% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.